BioSpace News Archive

Viseon Inc. announced that it has received Quality Management and CE Mark Certification for their MaxView® System device under the new MDR.

To promote its industry leadership in biorational and biostimulant product innovation, Valent BioSciences LLC has announced significant investments at several of its key research and development facilities.

Inc. revealed that PathogenDx (“PathogenDx” or “Company”), a leader in world-class microarray technology to advance molecular testing in human diagnostics, food and agricultural industries, placed No. 1232 on the annual Inc. 5000 list, the most prestigious ranking of the fastest-growing private companies in America.

Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) today announced that it has expanded its Board of Directors (the “Board”) from five (5) to eleven (11) and appointed six new directors following their election at its special meeting of stockholders held on August 15, 2022.

The global Human Immunodeficiency Virus (HIV) diagnostics market size is expected to reach USD 9.02 Billion in 2030 and register a revenue CAGR of 9.9% over the forecast period, according to the latest report by Reports and Data.

PharmaJet®, a company that has developed and commercialized a needle-free platform to more effectively administer drugs and biologics announced that its partner, University of Adelaide, has started a human trial of a DNA-based COVID-19 vaccine booster using the PharmaJet Tropis® Needle-free Injection System (NFIS).

The latest market analysis report published by Reports and Data, titled ‘Global Primary Care Physicians Market – Forecast to 2028,’ thoroughly examines the Primary Care Physicians industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Cushing Syndrome Market – Forecast to 2030,’ thoroughly examines the Cushing Syndrome industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Acute Conjunctivitis Market – Forecast to 2030,’ thoroughly examines the Acute Conjunctivitis industry to provide essential data & information for the targeted readers

The global artificial organs market is expected to reach USD 32.62 Billion by 2027, according to a new report by Emergen Research. The market is anticipated to witness a CAGR of 11.8% from 2020 to 2027.